This content is from: Premium Woodson Makes a Bullish Bet on Equities The Tiger Seed nearly doubled its net exposure at the end of April. By Stephen Taub May 26, 2022
This content is from: Premium Averill Partners Is Up 275 Percent in Two Years The top-performing hedge fund specializes in an unlikely part of the market. By Stephen Taub May 25, 2022
This content is from: Premium Seligman’s Short Strategy Has Paid Off Handsomely A rare inside look at how the hedge fund’s short portfolio has helped produce positive results this year. By Stephen Taub May 24, 2022
This content is from: Premium Hedge Funds Are Holding Their Breath on This Biopharma IPO Several prominent hedge funds disclosed sizable stakes in PepGen, which went public earlier this month. By Stephen Taub May 23, 2022
This content is from: Premium Third Point, Appaloosa, Element, and More Sharply Downsize Their U.S. Stock Portfolios One major firm, however, has aggressively bucked this trend. By Stephen Taub May 20, 2022
This content is from: Premium Will Melvin Capital Spark a Wave of Hedge Fund Closures? Over the years, hedge funds have shut down for many reasons other than lousy performance. By Stephen Taub May 20, 2022
